Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 02-Apr-24 12:12 PM View:  | Incyte Corp (INCY) | 28-Mar-24 | Grant | 403 | $56.97 | $22,958.90 | 3% 15.38K to 15.79K | |
| 03-Jan-24 12:08 PM View: | Incyte Corp (INCY) | 29-Dec-23 | Grant | 412 | $62.79 | $25,869.50 | 3% 14.97K to 15.38K | |
| 03-Oct-23 4:02 PM View: | Incyte Corp (INCY) | 29-Sep-23 | Grant | 379 | $57.77 | $21,894.80 | 3% 14.59K to 14.97K | |
| 05-Jul-23 4:00 PM View: | Incyte Corp (INCY) | 30-Jun-23 | Grant | 380 | $62.25 | $23,655.00 | 3% 14.21K to 14.59K | |
| 16-Jun-23 4:00 PM View: | Incyte Corp (INCY) | 14-Jun-23 | Grant | 2,505 | -- | -- | 21% 11.71K to 14.21K | |
| 12-Jun-23 4:30 PM View: | EXACT Sciences Corp. (EXAS) | 08-Jun-23 | Grant | 3,599 | -- | -- | 32% 11.1K to 14.7K | |
| 04-Apr-23 4:00 PM View: | Incyte Corp (INCY) | 31-Mar-23 | Grant | 318 | $72.27 | $22,981.90 | 3% 11.39K to 11.71K | 3% |
| 04-Jan-23 4:02 PM View: | Incyte Corp (INCY) | 30-Dec-22 | Grant | 294 | $80.32 | $23,614.10 | 3% 11.09K to 11.39K | (7%) |
| 04-Oct-22 4:00 PM View: | Incyte Corp (INCY) | 30-Sep-22 | Grant | 339 | $66.64 | $22,591.00 | 3% 10.76K to 11.09K | |
| 01-Jul-22 4:01 PM View: | Incyte Corp (INCY) | 30-Jun-22 | Grant | 321 | $75.97 | $24,386.40 | 3% 10.43K to 10.76K | (2%) |
| 17-Jun-22 4:01 PM View: | Incyte Corp (INCY) | 15-Jun-22 | Grant | 2,144 | -- | -- | 26% 8.29K to 10.43K | |
| 13-Jun-22 5:25 PM View: | EXACT Sciences Corp. (EXAS) | 09-Jun-22 | Grant | 5,606 | -- | -- | 102% 5.5K to 11.1K | |
| 24-May-22 4:13 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 20-May-22 | Option Exercise | 1,585 | -- | -- | 32% 4.96K to 6.55K | |
| 04-Apr-22 4:00 PM View: | Incyte Corp (INCY) | 31-Mar-22 | Grant | 326 | $79.42 | $25,890.90 | 4% 7.96K to 8.29K | (6%) |
| 04-Jan-22 10:00 PM View: | Incyte Corp (INCY) | 31-Dec-21 | Grant | 343 | $73.40 | $25,176.20 | 5% 7.62K to 7.96K | (3%) |
| 04-Oct-21 4:26 PM View: | Incyte Corp (INCY) | 30-Sep-21 | Grant | 321 | $68.78 | $22,078.40 | 4% 7.3K to 7.62K | (< 1%) |
| 02-Jul-21 7:16 AM View: | Incyte Corp (INCY) | 30-Jun-21 | Grant | 283 | $84.13 | $23,808.80 | 4% 7.02K to 7.3K | (< 1%) |
| 02-Jun-21 4:07 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 28-May-21 | Option Exercise | 1,686 | -- | -- | 51% 3.28K to 4.96K | |
| 28-May-21 7:01 AM View: | Incyte Corp (INCY) | 26-May-21 | Grant | 1,923 | -- | -- | 38% 5.09K to 7.02K | |
| 01-Apr-21 5:07 PM View: | Incyte Corp (INCY) | 31-Mar-21 | Grant | 298 | $81.27 | $24,218.50 | 6% 4.8K to 5.09K | 0% |
| 19-Mar-21 5:05 PM View: | EXACT Sciences Corp. (EXAS) | 18-Mar-21 | Grant | 2,929 | -- | -- | 100% 0 to 2.93K | |
| 05-Jan-21 4:55 PM View: | Incyte Corp (INCY) | 31-Dec-20 | Grant | 281 | $86.98 | $24,441.40 | 6% 4.51K to 4.8K | (< 1%) |
| 01-Oct-20 4:43 PM View: | Incyte Corp (INCY) | 30-Sep-20 | Grant | 260 | $89.74 | $23,332.40 | 6% 4.25K to 4.51K | (3%) |
| 01-Jul-20 4:51 PM View: | Incyte Corp (INCY) | 30-Jun-20 | Grant | 229 | $103.97 | $23,809.10 | 6% 4.03K to 4.25K | (16%) |
| 01-Jun-20 5:14 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 29-May-20 | Option Exercise | 1,878 | -- | -- | 134% 1.4K to 3.28K | |
| 28-May-20 4:13 PM View: | Incyte Corp (INCY) | 26-May-20 | Grant | 1,282 | -- | -- | 47% 2.74K to 4.03K | |
| 02-Apr-20 5:04 PM View: | Incyte Corp (INCY) | 31-Mar-20 | Grant | 287 | $73.23 | $21,017.00 | 12% 2.46K to 2.74K | 19% |
| 03-Jan-20 4:09 PM View: | Incyte Corp (INCY) | 31-Dec-19 | Grant | 231 | $87.32 | $20,170.90 | 10% 2.23K to 2.46K | < 1% |
| 02-Oct-19 4:08 PM View: | Incyte Corp (INCY) | 30-Sep-19 | Grant | 266 | $74.23 | $19,745.20 | 14% 1.96K to 2.23K | 18% |
| 15-Jul-19 5:01 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 11-Jul-19 | Payment of Exercise | 5,230 | $124.20 | $649,566.00 | (5%) 95.68K to 90.45K | (45%) |
| 02-Jul-19 4:31 PM View: | Incyte Corp (INCY) | 28-Jun-19 | Grant | 237 | $84.96 | $20,135.50 | 14% 1.72K to 1.96K | 3% |
| 31-May-19 4:03 PM View: | Agios Pharmaceuticals, Inc. (AGIO) | 31-May-19 | Option Exercise | 1,400 | -- | -- | 100% 0 to 1.4K | |
| 29-Apr-19 5:04 PM View: | Incyte Corp (INCY) | 26-Apr-19 | Grant | 1,520 | -- | -- | 749% 0.2K to 1.72K | |
| 02-Apr-19 5:08 PM View: | Incyte Corp (INCY) | 29-Mar-19 | Grant | 203 | $86.01 | $17,460.00 | 100% 0 to 0.2K | 2% |
| 05-Mar-19 8:13 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-19 | Grant | 9,428 | -- | -- | 11% 86.25K to 95.68K | |
| 04-Mar-19 5:37 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-19 | Payment of Exercise | 1,079 | $132.93 | $143,431.00 | (1%) 87.33K to 86.25K | (35%) |
| 11-Feb-19 6:21 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 07-Feb-19 | Payment of Exercise | 5,981 | $119.57 | $715,148.00 | (6%) 93.31K to 87.33K | (50%) |
| 12-Jul-18 5:23 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 10-Jul-18 | Market Sale | 5,241 | $131.11 | $687,148.00 | (5%) 98.55K to 93.31K | (37%) |
| 02-Mar-18 5:02 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 28-Feb-18 | Grant | 9,536 | -- | -- | 11% 89.01K to 98.55K | |
| 08-Feb-18 7:17 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 08-Feb-18 | Market Sale | 6,079 | $116.31 | $707,048.00 | (6%) 95.09K to 89.01K | (55%) |
| 08-Feb-18 7:17 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 06-Feb-18 | Grant | 48,228 | -- | -- | 103% 46.87K to 95.09K | |
| 12-Jul-17 6:11 PM View: | Alexion Pharmaceuticals, Inc. (ALXN) | 10-Jul-17 | Grant | 46,865 | -- | -- | 100% 0 to 46.87K | |
| 27-Apr-17 4:23 PM View: | Biogen Idec Inc. (BIIB) | 25-Apr-17 | Market Sale (Planned) | 9,892 | $290.00 | $2,868,680.00 | (48%) 20.7K to 10.81K | 3% |
| 14-Mar-17 7:32 PM View: | Biogen Idec Inc. (BIIB) | 13-Mar-17 | Market Sale (Planned) | 9,891 | $291.55 | $2,883,720.00 | (32%) 30.6K to 20.7K | 3% |
| 02-Mar-17 5:24 PM View: | Biogen Idec Inc. (BIIB) | 28-Feb-17 | Payment of Exercise | 3,054 | $279.35 | $853,135.00 | (9%) 33.65K to 30.6K | (1%) |
| 02-Mar-17 5:24 PM View: | Biogen Idec Inc. (BIIB) | 28-Feb-17 | Option Exercise | 6,780 | -- | -- | 25% 26.87K to 33.65K | |
| 25-Feb-16 5:13 PM View: | Biogen Idec Inc. (BIIB) | 23-Feb-16 | Payment of Exercise | 273 | $258.99 | $70,704.30 | (1%) 27.14K to 26.87K | (9%) |
| 25-Feb-16 5:13 PM View: | Biogen Idec Inc. (BIIB) | 23-Feb-16 | Option Exercise | 579 | -- | -- | 2% 26.56K to 27.14K | |
| 17-Feb-16 5:53 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-16 | Payment of Exercise | 1,699 | $247.22 | $420,027.00 | (6%) 28.26K to 26.56K | (14%) |
| 17-Feb-16 5:53 PM View: | Biogen Idec Inc. (BIIB) | 12-Feb-16 | Option Exercise | 3,859 | -- | -- | 16% 24.4K to 28.26K |